Manganese superoxide dismutase mimetic attenuates doxorubicin-induced myocardial injury via antioxidant and anti-inflammatory mechanisms involving Nrf2/HO-1 signaling

Doxorubicin (DOX) is a highly effective anticancer agent, but its clinical application is severely limited by dose-dependent cardiotoxicity. Despite its widespread use, effective strategies for preventing DOX-induced cardiac injury remain limited. In this study, we investigated the cardioprotective effects of an engineered manganese superoxide dismutase mimetic (MnSODm) against DOX-induced cardiotoxicity. MnSODm showed no significant cytotoxicity in H9C2 rat cardiomyocytes and dose-dependently alleviated DOX-induced cytotoxicity and morphological alterations, with optimal effects observed at 20 and 40 mg/L. MnSODm also reduced DOX-induced apoptosis, oxidative stress, and inflammatory responses in vitro. In a DOX-induced mouse model, MnSODm significantly improved cardiac index and reduced serum CK and LDH levels, histopathological abnormalities, and cardiac fibrosis. Moreover, MnSODm enhanced antioxidant defenses, as indicated by increased SOD, glutathione peroxidase, and catalase activities and reduced MDA levels. Mechanistically, MnSODm increased Nrf2 and HO-1 expression while reducing Keap1 expression, supporting the involvement of the Nrf2/HO-1 antioxidant pathway in its cardioprotective effects. MnSODm also attenuated inflammatory responses and preserved mitochondrial ultrastructure in DOX-treated cardiac tissue. Collectively, these findings demonstrate that MnSODm protects against DOX-induced cardiac injury, primarily through attenuation of oxidative stress and inflammation and modulation of the Nrf2/HO-1 antioxidant pathway, highlighting its potential as a cardioprotective strategy during DOX-based chemotherapy.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-80663-2
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Manganese superoxide dismutase mimetic attenuates doxorubicin-induced myocardial injury via antioxidant and anti-inflammatory mechanisms involving Nrf2/HO-1 signaling

Dezhuan Da, Chunyan Dang, Xiaohui Tai, 张旭霞 et al.
Scientific Reports
Chemotherapy-induced cardiotoxicity and mitigation
article

Manganese superoxide dismutase mimetic attenuates doxorubicin-induced myocardial injury via antioxidant and anti-inflammatory mechanisms involving Nrf2/HO-1 signaling

Dezhuan Da, Chunyan Dang, Xiaohui Tai, 张旭霞, Jiawei Liu, XUHUI ZHAO, Hongling Li, Li Xue, Yiwei An, Lingfang Zhang
article en

Abstract

Doxorubicin (DOX) is a highly effective anticancer agent, but its clinical application is severely limited by dose-dependent cardiotoxicity. Despite its widespread use, effective strategies for preventing DOX-induced cardiac injury remain limited. In this study, we investigated the cardioprotective effects of an engineered manganese superoxide dismutase mimetic (MnSODm) against DOX-induced cardiotoxicity. MnSODm showed no significant cytotoxicity in H9C2 rat cardiomyocytes and dose-dependently alleviated DOX-induced cytotoxicity and morphological alterations, with optimal effects observed at 20 and 40 mg/L. MnSODm also reduced DOX-induced apoptosis, oxidative stress, and inflammatory responses in vitro. In a DOX-induced mouse model, MnSODm significantly improved cardiac index and reduced serum CK and LDH levels, histopathological abnormalities, and cardiac fibrosis. Moreover, MnSODm enhanced antioxidant defenses, as indicated by increased SOD, glutathione peroxidase, and catalase activities and reduced MDA levels. Mechanistically, MnSODm increased Nrf2 and HO-1 expression while reducing Keap1 expression, supporting the involvement of the Nrf2/HO-1 antioxidant pathway in its cardioprotective effects. MnSODm also attenuated inflammatory responses and preserved mitochondrial ultrastructure in DOX-treated cardiac tissue. Collectively, these findings demonstrate that MnSODm protects against DOX-induced cardiac injury, primarily through attenuation of oxidative stress and inflammation and modulation of the Nrf2/HO-1 antioxidant pathway, highlighting its potential as a cardioprotective strategy during DOX-based chemotherapy.

Scientific Reports
Jiangsu University (CN), Gansu University of Traditional Chinese Medicine (CN), Gansu Provincial Hospital (CN)
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon